Headline News about Johnson & Johnson
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
September 25, 2024
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Via Benzinga
The Latest Analyst Ratings For Johnson & Johnson
September 19, 2024
Via Benzinga
Unpacking the Latest Options Trading Trends in Johnson & Johnson
September 12, 2024
Via Benzinga
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
September 20, 2024
Via Benzinga
Exposures
Product Safety
Metals in Tampons: FDA Initiates New Safety Measures and Testing
September 11, 2024
Via Benzinga
Exposures
Product Safety
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Court Orders Johnson & Johnson To Compensate Auris Health Shareholders $1B
September 04, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.